H2AX and breast cancer: We show a significant decrease in the total level of H2AX protein in various pathophysiological conditions associated with chronic oxidative stress, i.e. genetic inactivation of antioxidant enzymes, ageing, aggressive BC and successive cycles of chemotherapy in patients.